Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(14%)
Results Posted
100%(2 trials)
Terminated
1(14%)

Phase Distribution

Ph not_applicable
4
57%
Ph phase_2
2
29%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(2)
Terminated(3)
Other(1)

Detailed Status

Withdrawn2
Completed2
unknown1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (33.3%)
N/A4 (66.7%)

Trials by Status

withdrawn229%
unknown114%
terminated114%
completed229%
recruiting114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
7